Evaluation of the Effect of Biomarker Levels Associated with Disease Severity on Mortality in COVID-19 Patients in the Gaziantep Region of Turkey

被引:0
|
作者
Gurbuz, Huseyin [1 ]
Bayrakci, Sinem [2 ]
Bayrakci, Onur [3 ]
Cicek, Hulya [4 ]
机构
[1] Dr Ersin Arslan Training & Res Hosp, Dept Emergency Med, Gaziantep, Turkiye
[2] Dr Ersin Arslan Training & Res Hosp, Dept Intens Care, Gaziantep, Turkiye
[3] Dr Ersin Arslan Training & Res Hosp, Dept Thorac Surg, Gaziantep, Turkiye
[4] Gaziantep Univ, Fac Med, Dept Med Biochem, Gaziantep, Turkiye
关键词
COVID-19; D-Dimer; CK-MB; Ferritin; Cardiac troponin-I; TROPONIN; HYPERTENSION; DEATH;
D O I
10.18016/ksutarimdoga.vi.1189752
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
This study aimed to investigate the effect of clinical and some specific laboratory parameters on the prognosis and mortality of critically ill COVID-19 patients who need to be followed in the intensive care unit (ICU). This is a retrospective cohort study. A total of 180 patients treated in the ICU were included in the study. The data of clinical and levels of D-dimer, cardiac troponin I (cTnI), Ferritin, and CK-MB were researched. The multivariate and univariate logistic regression models were employed to investigate the risk factors affiliated with in-hospital death. There was a significant difference in mortality between women and men (p=0.002). Hypertension was the most common comorbid disease, mortality was detected to be significantly greater in patients over 65 years of age. The serum D-dimer, cTnI, CK-MB, and ferritin levels were found to be higher in patients at risk. In the multivariate logistic regression model, we detected that ferritin above 300 mu g/l (p=0.05) alongside cancer was associated with mortality. This study showed that advanced age is an important risk factor as well as the mortality of patients with cancer -especially those with a ferritin value above 300 mu g/l and patients with a high cTnI value.
引用
收藏
页码:1239 / 1245
页数:7
相关论文
共 50 条
  • [31] Evaluation of protein C and S levels in patients with COVID-19 infection and their relation to disease severity
    Elshafie, Ahmed
    Foda, Enas
    Yousef, Mahmoud M. G.
    Abd El-Naby, Kareem A.
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01):
  • [32] Evaluation of protein C and S levels in patients with COVID-19 infection and their relation to disease severity
    Ahmed Elshafie
    Enas Foda
    Mahmoud M. G. Yousef
    Kareem A. Abd El-Naby
    The Egyptian Journal of Internal Medicine, 35
  • [33] Impacts of Type 2 Diabetes on Disease Severity, Therapeutic Effect, and Mortality of Patients With COVID-19
    Wang, Xiaoli
    Liu, Zhengru
    Li, Jiao
    Zhang, Jixiang
    Tian, Shan
    Lu, Shimin
    Qi, Mingming
    Ma, Jingjing
    Qiu, Bo
    Dong, Weiguo
    Xu, Yu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (12):
  • [34] Effect of magnesium on severity and mortality of COVID-19 patients: A systematic review
    Avan, Razieh
    Mazidimoradi, Afrooz
    Salehiniya, Hamid
    JOURNAL OF ACUTE DISEASE, 2022, 11 (04) : 120 - 126
  • [35] The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
    Yang, Wenxing
    Sun, Xuehong
    Zhang, Jun
    Zhang, Kui
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [36] Cancer is associated with coronavirus disease (COVID-19) severity and mortality: A pooled analysis
    Cheruiyot, Isaac
    Kipkorir, Vincent
    Ngure, Brian
    Misiani, Musa
    Munguti, Jeremiah
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 45 : 179 - 184
  • [37] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    CLINICAL LABORATORY, 2022, 68 (02) : 291 - 297
  • [38] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    CLINICAL LABORATORY, 2021,
  • [39] Retinol Levels and Severity of Patients with COVID-19
    Carvalho, Maria Clara da Cruz
    Araujo, Julia Kaline Carvalho Pereira
    da Silva, Ana Gabriella Costa Lemos
    da Silva, Nayara Sousa
    de Araujo, Nathalia Kelly
    Luchessi, Andre Ducati
    Ribeiro, Karla Danielly da Silva
    Silbiger, Vivian Nogueira
    NUTRIENTS, 2023, 15 (21)
  • [40] An immune-based biomarker signature is associated with mortality in COVID-19 patients
    Abers, Michael S.
    Delmonte, Ottavia M.
    Ricotta, Emily E.
    Fintzi, Jonathan
    Fink, Danielle L.
    de Jesus, Adriana A. Almeida
    Zarember, Kol A.
    Alehashemi, Sara
    Oikonomou, Vasileios
    Desai, Jigar, V
    Canna, Scott W.
    Shakoory, Bita
    Dobbs, Kerry
    Imberti, Luisa
    Sottini, Alessandra
    Quiros-Roldan, Eugenia
    Castelli, Francesco
    Rossi, Camillo
    Brugnoni, Duilio
    Biondi, Andrea
    Bettini, Laura Rachele
    D'Angio', Mariella
    Bonfanti, Paolo
    Castagnoli, Riccardo
    Montagna, Daniela
    Licari, Amelia
    Marseglia, Gian Luigi
    Gliniewicz, Emily F.
    Shaw, Elana
    Kahle, Dana E.
    Rastegar, Andre T.
    Stack, Michael
    Myint-Hpu, Katherine
    Levinson, Susan L.
    DiNubile, Mark J.
    Chertow, Daniel W.
    Burbelo, Peter D.
    Cohen, Jeffrey, I
    Calvo, Katherine R.
    Tsang, John S.
    Su, Helen C.
    Gallin, John, I
    Kuhns, Douglas B.
    Goldbach-Mansky, Raphaela
    Lionakis, Michail S.
    Notarangelo, Luigi D.
    JCI INSIGHT, 2021, 6 (01)